IDH2 and chronic kidney disease: In conclusion, our study demonstrated for the first time that tubular MYDGF promotes the remodeling of mitochondrial homeostasis and alleviates kidney injury in CKD, at least in part by regulating the expression of IDH2, suggesting that targeting tubular MYDGF may be an effective therapeutic strategy for patients with CKD (Figure8).